Characterization of amorphous and co-amorphous simvastatin formulations prepared by spray drying

Molecules

Volumn 20, Issue 12, 2015, Pages 21532-21548

  Craye, Goedele ^a,b   Löbmann, Korbinian ^c   Grohganz, Holger ^c   Rades, Thomas ^c   Laitinen, Riikka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Co amorphous; Dissolution; Energy dispersive X ray spectroscopy; Solubility; Spray drying; Stability

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; SIMVASTATIN; SURFACTANT;

CHEMISTRY; DESICCATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; INFRARED SPECTROSCOPY; PHARMACEUTICS; PROCEDURES;

ANTICHOLESTEREMIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; DESICCATION; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; SIMVASTATIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84954338812     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201219784     Document Type: Article

References (49)

1. Williams, H.D.; Trevaskis, N.L.; Charman, S.A.; Shanker, R.M.; Charman, W.N.; Pouton, C.W.; Porter, C.J.H. Strategies to address low drug solubility in discovery and development. Pharmacol. Rev. 2013, 65, 315-499.
2. Brough, C.; Williams, R.O., III. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. Int. J. Pharm. 2013, 453, 157-166.
3. Vo, C.L.; Park, C.; Lee, B. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur. J. Pharm. Biopharm. 2013, 85, 799-813.
4. Zheng, E.; Jain, A.; Papoutsakis, D.; Dannenfelser, R.M.; Panicucci, R.; Garad, S. Selection of oral bioavailability enhancing formulations during drug discovery. Drug. Dev. Ind. Pharm. 2012, 38, 235-247.
5. Janssens, S.; van den Mooter, G. Review: physical chemistry of solid dispersions. J. Pharm. Pharmacol. 2009, 61, 1571-1586.
6. Srinarong, P.; de Waard, H.; Frijlink, H.W.; Hinrichs, W.L.J. Improved dissolution behavior of lipophilic drugs by solid dispersions: The production process as starting point for formulation considerations. Expert Opin. Drug Deliv. 2011, 8, 1121-1140.
7. Laitinen, R.; Löbmann, K.; Grohganz, H.; Strachan, C.; Rades, T. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: Physical properties and stability. Mol. Pharm. 2014, 11, 2381-2389.
8. Löbmann, K.; Strachan, C.; Grohganz, H.; Rades, T.; Korhonen, O.; Laitinen, R. Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. Eur. J. Pharm. Biopharm. 2012, 81, 159-169.
9. Laitinen, R.; Löbmann, K.; Strachan, C.J.; Grohganz, H.; Rades, T. Emerging trends in the stabilization of amorphous drugs. Int. J. Pharm. 2013, 30, 65-79.
10. Löbmann, K.; Grohganz, H.; Laitinen, R.; Strachan, C.; Rades, T. Amino acids as co-amorphous stabilizers for poorly water soluble drugs-Part 1: Preparation, stability and dissolution enhancement. Eur. J. Pharm. Biopharm. 2013, 85, 873-881.
11. Gao, Y.; Liao, J.; Qi, X.; Zhang, J. Coamorphous repaglinide-saccharin with enhanced dissolution. Int. J. Pharm. 2013, 450, 290-295.
12. Hu, Y.; Gniado, K.; Erxleben, A.; McArdle, P. Mechanochemical reaction of sulfathiazole with carboxylic acids: Formation of a cocrystal, a salt, and coamorphous colids. Cryst. Growth. Des. 2014, 14, 803-813.
13. Dengale, S.J.; Ranjan, O.P.; Hussen, S.S.; Krishna, B.S.M.; Musmade, P.B.; Shenoy, G.G.; Bhat, K. Preparation and characterization of co-amorphous ritonavir-indomethacin systems by solvent evaporation technique: Improved dissolution behavior and physical stability without evidence of intermolecular interactions. Eur. J. Pharm. Sci. 2014, 62, 57-64.
14. Shayanfar, A.; Jouyban, A. Drug-drug coamorphous systems: Characterization and physicochemical properties of coamorphous atorvastatin with carvedilol and glibenclamide. J. Pharm. Innov. 2013, 8, 218-228.
15. Martínez, L.M.; Videa, M.; López-Silva, G.A.; de los Reyes, C.A.; Cruz-Angeles, J.; González, N. Stabilization of amorphous paracetamol based systems using traditional and novel strategies. Int. J. Pharm. 2014, 477, 294-305.
16. Jensen, K.T.; Blaabjerg, L.I.; Lenz, E.; Bohr, A.; Grohganz, H.; Kleinebudde, P.; Rades, T.; Löbmann, K. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts. J. Pharm. Pharmacol. 2015.
17. Démuth, B.; Nagy, Z.K.; Balogh, A.; Vigh, T.; Marosi, G.; Verreck, G.; van Assche, I.; Brewster, M.E. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations. Int. J. Pharm. 2015, 486, 268-286.
18. Koltzenburg, S. Formulation of problem drugs -and they are all problem drugs. In Solubility Enhancement with BASF Pharma Polymers. Solubilizer Compendium; Reintjes, T., Ed.; BASF SE: Lampertheim, Germany, 2011; p. 22.
19. Mukerjee, P.; Mysels, K.J. Critical micelle concentrations of aqueous surfactant systems. Nat. Stand. Ref. Data Ser. Nat. Bur. Stand. 1970.
20. Patist, A.; Bhagwat, S.S.; Penfield, K.W.; Aikens, P.; Shah, D.O. On the measurement of critical micelle concentrations of pure and technical-grade nonionic surfactants. J. Surfactants Deterg. 2000, 3, 53-58.
21. Available online: http://www4.mpbio.com/ecom/docs/proddata.nsf/03d5991c3a7e7f0d8525792e00243e31/b8dd4c6faf0859048525663c0070508e (accessed on 20 November 2015).
22. Cadwallader, D.E.; Devendra, K.M. Effect of macromolecules on aqueous solubility of cholesterol and hormone drugs. J. Pharm. Sci. 1981, 70, 442-446.
23. Garekani, H.A.; Sadeghi, F.; Ghazi, A. Increasing the aqueous solubility of acetaminophen in the presence of polyvinylpyrrolidone and investigation of the mechanisms involved. Drug Dev. Ind. Pharm. 2003, 29, 173-179.
24. gdrug: In vitro and in vivo evaluations. Pharm. Res. 2005, 22, 990-998.
25. Zhang, Y.; Liu, Y.; Luo, Y.; Yao, Q.; Zhong, Y.; Tian, B.; Tang, X. Extruded soluplus/SIM as an oral delivery system: Characterization, interactions, in vitro and in vivo evaluations. Drug Deliv. 2015.
26. Singla, N.; Gupta, G.D.; Kohli, K.; Singla, A.K. A discriminatory and biorelevant dissolution test method for simvastatin drug products. Dissol. Technol. 2009, 16, 11-13.
27. Takeuchi, H.; Nagira, S.; Yamamoto, H.; Kawashima, Y. Solid dispersion particles of tolbutamide with fine silica particles by the spray-drying method. Powder Technol. 2004, 195, 141-187.
28. Yu, D.G.; Zhu, L.M.; Branford-White, C.J.; Yang, J.H.; Wang, X.; Li, Y.; Qian, W. Solid dispersions in the form of electrospun core-sheath nanofibers. Int. J. Nanomed. 2012, 6, 3271-3280.
29. Roberts, M.; Ehtezazi, T.; Compernolle, A.; Amin, K. The effect of spray drying on the compaction properties of hypromellose acetate succinate. Drug Dev. Ind. Pharm. 2011, 37, 268-273.
30. Millqvist-Fureby, A.; Malmsten, M.; Bergenståhl, B. Spray-drying of trypsin-Surface characterisation and activity preservation. Int. J. Pham. 1999, 188, 243-253.
31. Sinko, P.J. Martin's Physical Pharmacy and Pharmaceutical Sciences, 6th ed.; Lippincott Williams & Wilkins: Baltimore, MD, USA, 2011; p. 369.
32. Mattern, M.; Winter, G.; Kohnert, U.; Lee, G. Formulation of proteins in vacuum-dried glasses. II. Process and storage stability in sugar-free amino acid systems. Pharm. Dev. Technol. 1999, 4, 199-208.
33. Dave, R.H.; Patel, A.D.; Donahue, E.; Patel, H.H. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin. Drug Dev. Ind. Pharm. 2012, 38, 930-939.
34. Nasr, H.E.; Gaffar, M.S.; Abdel-Kareem, O.; Abd El-Aziz, F. Morphological, rheological and ultrasonic characterizations of ECO-friendly microemulsion lattices based on acrylate monomers. J. Am. Sci. 2010, 6, 897-910.
35. Da Costa, M.A.; Seiceira, R.C.; Rodrigues, C.R.; Hoffmeister, C.R.D.; Cabral, L.M.; Rocha, H.V.A. Efavirenz dissolution enhancement I: Co-micronization. Pharmaceutics 2013, 5, 1-22.
36. Bhise, S.B.; Mookkan, S. Formulation and evaluation of novel FDCs of antitubercular drugs. J. Pharm. Res. 2009, 2, 437-444.
37. Kaminska, E.; Adrjanowicz, K.; Kaminski, K.; Wlodarczyk, P.; Hawelek, L.; Kolodziejczyk, K.; Tarmacka, M.; Zakowiecki, D.; Kacmarcyk-Sedlak, I.; Pilch, J.; et al. A new way of stabilization of furosemide upon cryogenic ginding by using acylated saccharides matrices. The role of hydrogen bonds in decomposition mechanism. Mol. Pharmacol. 2013, 10, 1824-1835.
38. Grzybowska, K.; Paluch, M.; Wlodarczyk, P.; Kaminski, K.; Hawelek, L. Enhancement of amorphous celecoxib stability by mixing it with octaacetylmaltose: the molecular dynamics study. Mol. Pharm. 2012, 9, 894-904.
39. Marsac, P.J.; Li, T.; Taylor, L.S. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm. Res. 2009, 26, 139-151.
40. Marsac, P.J.; Konno, H.; Taylor, L.S. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharm. Res. 2006, 23, 2306-2316.
41. Mosquera-Giraldo, L.I.; Trasi, N.S.; Taylor, L.S. Impact of surfactants on the crystal growth of amorphous celecoxib. Int. J. Pharm. 2014, 461, 251-257.
42. Prosser, A.J.; Franses, E.I. Infrared reflection absorption spectroscopy (IRRAS) of aqueous nonsurfactant salts, ionic surfactants, and mixed ionic surfactants. Langmuir 2002, 18, 9234-9242.
43. Viana, R.B.; da Silva, A.B.F.; Pimentel, A.S. Infrared spectroscopy of anionic, cationic, and zwitterionic surfactants. Adv. Phys. Chem. 2012.
44. Kawai, T.; Umemura, J.; Takenaka, T. Fourier transform infrared study on the phase transitions of a sodium dodecyl sulfate-water system. Bull. Inst. Chem. Res. Kyoto Univ. 1983, 61, 314-323.
45. Heikkinen, A.T.; DeClerck, L.; Löbmann, K.; Grohganz, H.; Rades, T.; Laitinen, R. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media. Die Pharm. 2015, 70, 452-457.
46. Augustijns, P.; Brewster, M.E. Supersaturating drug delivery systems: Fast is not necessarily good enough. J. Pharm. Sci. 2012, 101, 7-9.
47. Chen, J.; Ormes, J.D.; Higgins, J.D.; Taylor, L.S. Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles. Mol. Pharm. 2015, 12, 533-541.
48. Priemel, P.A.; Laitinen, R.; Barthold, S.; Grohganz, H.; Lehto, V.P.; Rades, T.; Strachan, C.J. Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug-polymer mixtures. Int. J. Pharm. 2013, 456, 301-306.
49. Collier, J.W.; Shah, R.B.; Gupta, A.; Sayeed, V.; Habib, M.J.; Khan, M.A. Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate. AAPS PharmSciTech 2010, 11, 818-825.